• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VICRYL RAPIDE SUTURE 36"(90CM) 2-0 UND; SUTURE, ABSORBABLE, SYNTHETIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VICRYL RAPIDE SUTURE 36"(90CM) 2-0 UND; SUTURE, ABSORBABLE, SYNTHETIC Back to Search Results
Catalog Number VR917
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Wound Dehiscence (1154); Erythema (1840); Foreign Body Reaction (1868); Inflammation (1932); Pain (1994)
Date of Event 08/25/2025
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4) this report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.A manufacturing record evaluation was performed for the finished device lot number, and no related non-conformances were identified.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.Attempts are being made to obtain the following information.To date no response has been provided.If further details are received at a later date a supplemental medwatch will be sent: is yishayading wet compress a prescription product? is rehabilitation new liquid wet compress a prescription product? confirm the procedure date.(b)(6)?) confirm the event date.(b)(6)?) please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure.On what tissue was the suture used? what was the tissue condition (normal, thin, calcified, fragile, diseased)? how was the suture placed (interrupted or continuous)? how was the suture originally tied (multiple knots, square knot, etc.)? please describe any additional medical/surgical intervention required for this suture event including dates and results.Did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? were any pre-op cleansing procedures or products changed recently? if yes, please describe.Does the patient have a known allergic history to any medical devices, food and/or medication? was allergy testing performed? if so, please describe with results.Are there any photos available? what is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status?.
 
Event or Problem Description
It was reported that a patient underwent a vaginal delivery with routine perineal incision on (b)(6) 2025 and suture was used.On the 5th day after surgery, (b)(6) 2025, the perineal incision suture was removed, and it was found that the incision site was slightly red and painful.No wound was found to have opened, indicating a foreign body sensation or rejection reaction of the suture.Five days after discharge, the patient found pain and discomfort in the perineal wound.On the 12th day after surgery (b)(6) 2025, the patient visited the outpatient department and checked that the perineal incision wound had opened by about 2cmx0.3cmx0.1cm, with no abnormal secretion exuding.The doctor gave yishayading wet compress to the wound+rehabilitation new liquid wet compress to the wound and instructed the patient to clean the perineum with water after two bowel movements.The patient lay flat on the right side as much as possible.After one week, the wound gradually healed.No redness or swelling.Additional information was requested.
 
Additional Manufacturer Narrative
Product complaint#: (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by ethicon inc, or its employees that the report constitutes an admission that the product, ethicon inc or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Additional information was requested, and the following was obtained: confirm the procedure date.On (b)(6) 20?) yes.Confirm the event date.(august 25?) yes.On what tissue was the suture used? perineal skin.How was the suture placed (interrupted or continuous)? continuous.Are there any photos available? no.The hospital feedback that the tissue layer sutured during the surgery was perineal skin.The patient's wound healing condition improved after symptomatic treatment.No subsequent adverse event reports were received.The following information was requested but unavailable: is yishayading wet compress a prescription product? is rehabilitation new liquid wet compress a prescription product? please provide the patient's demographic information including age, gender, weight, bmi at the time of index procedure.On what tissue was the suture used? what was the tissue condition (normal, thin, calcified, fragile, diseased)? how was the suture placed (interrupted or continuous)? how was the suture originally tied (multiple knots, square knot, etc.)? please describe any additional medical/surgical intervention required for this suture event including dates and results.Did the operating surgeon observe any suture deficiency or anomaly before, during, after the suture placement or during any re-operation? were any pre-op cleansing procedures or products changed recently? if yes, please describe.Does the patient have a known allergic history to any medical devices, food and/or medication? was allergy testing performed? if so, please describe with results.What is the physician¿s opinion as to the etiology of or contributing factors to this event? what is the patient's current status?.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VICRYL RAPIDE SUTURE 36"(90CM) 2-0 UND
Common Device Name
SUTURE, ABSORBABLE, SYNTHETIC
Manufacturer (Section D)
ETHICON INC.
1000 route 202
raritan NJ 08869
Manufacturer (Section G)
ETHICON INC.-BRAZIL
rodovia presidente dutra
km 154
sao paulo 12240
BR   12240
Manufacturer Contact
orla o'mahony
1000 route 202
raritan, NJ 08869
3035526892
MDR Report Key23547914
Report Number2210968-2025-12811
Device Sequence Number21153181
Product Code GAM
UDI-Device Identifier10705031134768
UDI-Public(01)10705031134768(17)300131(10)AW3935
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K033746
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,User Facility,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 12/11/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Catalogue NumberVR917
Device Lot NumberAW3935
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/23/2025
Supplement Date Received by Manufacturer11/17/2025
Initial Report FDA Received Date11/13/2025
Supplement Report FDA Received Date12/11/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured02/25/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-